Literature DB >> 19632180

MafB restricts M-CSF-dependent myeloid commitment divisions of hematopoietic stem cells.

Sandrine Sarrazin1, Noushine Mossadegh-Keller, Taro Fukao, Athar Aziz, Frederic Mourcin, Laurent Vanhille, Louise Kelly Modis, Philippe Kastner, Susan Chan, Estelle Duprez, Claas Otto, Michael H Sieweke.   

Abstract

While hematopoietic stem cell (HSC) self-renewal is well studied, it remains unknown whether distinct control mechanisms enable HSC divisions that generate progeny cells with specific lineage bias. Here, we report that the monocytic transcription factor MafB specifically restricts the ability of M-CSF to instruct myeloid commitment divisions in HSCs. MafB deficiency specifically enhanced sensitivity to M-CSF and caused activation of the myeloid master-regulator PU.1 in HSCs in vivo. Single-cell analysis revealed that reduced MafB levels enabled M-CSF to instruct divisions producing asymmetric daughter pairs with one PU.1(+) cell. As a consequence, MafB(-/-) HSCs showed a PU.1 and M-CSF receptor-dependent competitive repopulation advantage specifically in the myelomonocytic, but not T lymphoid or erythroid, compartment. Lineage-biased repopulation advantage was progressive, maintained long term, and serially transplantable. Together, this indicates that an integrated transcription factor/cytokine circuit can control the rate of specific HSC commitment divisions without compromising other lineages or self-renewal.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19632180     DOI: 10.1016/j.cell.2009.04.057

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  65 in total

1.  High MafB expression following burn augments monocyte commitment and inhibits DC differentiation in hemopoietic progenitors.

Authors:  Kirstin Howell; Joseph Posluszny; Li K He; Andrea Szilagyi; John Halerz; Richard L Gamelli; Ravi Shankar; Kuzhali Muthu
Journal:  J Leukoc Biol       Date:  2011-10-07       Impact factor: 4.962

2.  MafB as a type I interferon rheostat.

Authors:  Hozumi Motohashi; Kazuhiko Igarashi
Journal:  Nat Immunol       Date:  2010-08       Impact factor: 25.606

Review 3.  Erythropoietin receptor response circuits.

Authors:  Don M Wojchowski; Pradeep Sathyanarayana; Arvind Dev
Journal:  Curr Opin Hematol       Date:  2010-05       Impact factor: 3.284

4.  Developmental biology: Instructions writ in blood.

Authors:  Tariq Enver; Sten Eirik W Jacobsen
Journal:  Nature       Date:  2009-09-10       Impact factor: 49.962

Review 5.  Forcing cells to change lineages.

Authors:  Thomas Graf; Tariq Enver
Journal:  Nature       Date:  2009-12-03       Impact factor: 49.962

Review 6.  Regulation of myelopoiesis by proinflammatory cytokines in infectious diseases.

Authors:  Yukino Chiba; Izuru Mizoguchi; Hideaki Hasegawa; Mio Ohashi; Naoko Orii; Taro Nagai; Miyaka Sugahara; Yasunori Miyamoto; Mingli Xu; Toshiyuki Owaki; Takayuki Yoshimoto
Journal:  Cell Mol Life Sci       Date:  2017-12-07       Impact factor: 9.261

Review 7.  A novel role for coinhibitory receptors/checkpoint proteins in the immunopathology of sepsis.

Authors:  Eleanor A Fallon; Bethany M Biron-Girard; Chun-Shiang Chung; Joanne Lomas-Neira; Daithi S Heffernan; Sean F Monaghan; Alfred Ayala
Journal:  J Leukoc Biol       Date:  2018-02-02       Impact factor: 4.962

8.  Diagnostic value of blood gene expression signatures in active tuberculosis in Thais: a pilot study.

Authors:  N Satproedprai; N Wichukchinda; S Suphankong; W Inunchot; T Kuntima; S Kumpeerasart; S Wattanapokayakit; S Nedsuwan; H Yanai; K Higuchi; N Harada; S Mahasirimongkol
Journal:  Genes Immun       Date:  2015-03-12       Impact factor: 2.676

9.  Environment drives selection and function of enhancers controlling tissue-specific macrophage identities.

Authors:  David Gosselin; Verena M Link; Casey E Romanoski; Gregory J Fonseca; Dawn Z Eichenfield; Nathanael J Spann; Joshua D Stender; Hyun B Chun; Hannah Garner; Frederic Geissmann; Christopher K Glass
Journal:  Cell       Date:  2014-12-04       Impact factor: 41.582

Review 10.  Rapamycin and the transcription factor C/EBPbeta as a switch in osteoclast differentiation: implications for lytic bone diseases.

Authors:  Jeske J Smink; Achim Leutz
Journal:  J Mol Med (Berl)       Date:  2009-11-27       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.